Pharmafile Logo

Volt Pharma Associates

VPA supports life sciences companies, investors and academic institutes in developing new products, technologies and innovative approaches. VPA’s aim is to solve our clients’ product research, development and commercialisation challenges so they can achieve their business goals.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Genesis Research Group

Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise,…

View Profile

Company Details

Engesserstrasse 4B, Freiburg, 79114, Germany
+49 172 6340202

 Latest Content from PMHub 

FINDING OPPORTUNITIES IN YOUR DIGITAL MARKETING STRATEGY

White Papers and Resources | November 6, 2024 | IGNIFI

Digital marketing serves as a critical component within a successful omnichannel strategy, guaranteeing seamless experiences for healthcare professionals and patients across various online platforms. It plays a pivotal role in...

Why is storytelling changing the way we do health comms?

White Papers and Resources | November 5, 2024 | Mednet

Principal Medical Writer, Dr Alexandra Loveday explores the importance of storytelling in health communications.

EatMoreFruit announces launch of European PR Network

Press Releases | November 4, 2024 | EatMoreFruit

EatMoreFruit, a UK top 10 independent healthcare communication agency, today announced the launch of its European Network to support new and existing clients across the diagnostics, med tech, life sciences,...

What if you could shape your next campaign messaging with the media before launch?

Press Releases | November 4, 2024 | EatMoreFruit

Sometimes you just can’t see the wood from the trees. Teams gets so focussed on the technology or treatment you’re selling that the inevitable outcome is a feature-peddling monologue where...

Is your influenza clinical trial prepared for the upcoming flu season? Part 3

This blog will discuss some important aspects to consider to maximise patient retention on your flu clinical trials. For more information on patient recruitment considerations, check out our previous blogs...

Is your influenza clinical trial prepared for the upcoming flu season? Part 2

Around 86% of clinical trials do not meet patient recruitment goals, ultimately failing to improve patient outcomes and resulting in financial losses for sponsors and research sites (Rangu and Maxwell,...

Is your influenza clinical trial prepared for the upcoming flu season? Part 1

The Northern Hemisphere flu season is fast approaching, bringing with it a multitude of challenges for respiratory clinical trials. The exact dates of the flu season in the Northern Hemisphere...

Recognizing C diff Awareness Month in 2024

Press Releases | October 31, 2024 | Medscape Education

Every year, the medical community recognizes the month of November as Clostridioides difficile (C. diff) Awareness month. C. diff is a public health threat that causes around 500,000 infections every...

AI-Driven Platforms Enhance Drug Discovery Collaborations

Press Releases | October 31, 2024 | Springer Nature

Generative AI platforms are revolutionizing drug discovery, driving significant biopharma dealmaking by enabling the design of innovative small-molecule and biologic drug candidates.

Medscape Education presenting at the 17th Annual European CME Forum

Press Releases | October 31, 2024 | Medscape Education

With a commitment to advancing the field of continuing medical education, the Medscape team will be travelling to Madrid for the 17th Annual European CME Forum and bringing with them...